Nuvalent Inc logo

Nuvalent Inc

$ 16.52 -0.14 (-0.84%) 12:39 PM EST
P/E:
At Loss
P/B:
2.94
Market Cap:
$ 799.78M
Enterprise V:
$ 807.66M
Volume:
11.15K
Avg Vol (2M):
176.30K
Volume:
11.15K
Market Cap $:
799.78M
PE Ratio:
At Loss
Avg Vol (2-Month):
176.30K
Enterprise Value $:
807.66M
PB Ratio:
2.94
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Nuvalent Inc
NAICS : 325412 SIC : 2834
One Broadway, 14th Floor, Cambridge, MA, USA, 02142
Description
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.96
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 54.03
9-Day RSI 54.13
14-Day RSI 54.71
6-1 Month Momentum % -14.72
12-1 Month Momentum % -31.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 25.79
Quick Ratio 25.79
Cash Ratio 25.6

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -31
ROA % -25.57
ROIC % -1302.64
ROCE % -26.58

Financials (Next Earnings Date:2022-11-10 Est.)

NUVL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:NUVL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.49
Beta 0
Volatility % 133.55
14-Day RSI 54.71
14-Day ATR ($) 1.442044
20-Day SMA ($) 16.016
12-1 Month Momentum % -31.43
52-Week Range ($) 7.09 - 40.8214
Shares Outstanding (Mil) 48.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nuvalent Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More